Pfizer Admits Myocarditis Risk for 5-12 Year-Olds Requires 5-Year Study
Nov 15 2021

Clinical trials conducted by drug giant Pfizer were too short to determine long-term myocarditis risks in children who take the Covid-19 vaccine, the company admitted in documents submitted to the FDA.

The information appears on page 11 of an FDA advisory committee briefing (1) from late last month, where Pfizer even admits its sample size of clinical trial volunteers was also too small to detect myocarditis risks in children aged 5 to 12.

(1) Vaccines and Related Biological Products
Advisory Committee October 26, 2021
Meeting Document

Nova Scotia: All Public Schools to Receive Automated External Defibrillators
March 16 2021

Heart Attack Data Withheld for Fear of Losing Money! – Dr Aseem Malhotra
Nov 25 2021

‘They aren’t going to publish their findings, they are concerned about losing research money’
Dr Aseem Malhotra reveals a cardiology researcher found similar results to a new report showing an increase in risk of heart attack following the mRNA COVID vaccine.

“We know since July there have been almost 10,000 excess non covid deaths. And a significant amount of those deaths have been driven by circulatory disease, in other words, heart attack and stroke. There has been a 30 percent increase of people dying at home, often from cardiac arrest.”